Share-based Payment Arrangement, Expense of InMed Pharmaceuticals Inc. from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
InMed Pharmaceuticals Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $25,564, a 10% increase year-over-year.
  • InMed Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $22,610, a 85% decline year-over-year.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2025 was $28,964, a 79% decline from 2024.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2024 was $137,714, a 50% decline from 2023.
  • InMed Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $278,154, a 60% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

InMed Pharmaceuticals Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $22,610 $25,564 +$2,405 +10% 01 Oct 2025 31 Dec 2025 10-Q 11 Feb 2026 2026 Q2
Q3 2025 $20,205 $20,205 -$8,759 -30% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q2 2025 $28,964 $63,613 -$102,567 -263% 01 Apr 2025 30 Jun 2025 10-Q 06 Nov 2025 2026 Q1
Q1 2025 $131,531 $40,454 -$14,851 -27% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q3
Q4 2024 $146,382 $23,159 +$4,895 +27% 01 Oct 2024 31 Dec 2024 10-Q 11 Feb 2026 2026 Q2
Q3 2024 $141,487 $28,964 +$3,773 +15% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $137,714 $38,954 -$1,524 -3.8% 01 Apr 2024 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q1 2024 $139,238 $55,305 +$4,948 +9.8% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q3
Q4 2023 $134,290 $18,264 -$52,374 -74% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2025 Q2
Q3 2023 $186,664 $25,191 -$91,490 -78% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q2 2023 $278,154 $40,478 -$136,410 -77% 01 Apr 2023 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q1 2023 $414,564 $50,357 -$144,728 -74% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q3
Q4 2022 $559,292 $70,638 -$144,141 -67% 01 Oct 2022 31 Dec 2022 10-Q 13 Feb 2024 2024 Q2
Q3 2022 $703,433 $116,681 +$5,539 +5% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q2 2022 $697,894 $176,888 -$43,962 -20% 01 Apr 2022 30 Jun 2022 10-K 29 Sep 2023 2023 FY
Q1 2022 $741,856 $195,085 -$12,217 -5.9% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q3
Q4 2021 $754,073 $214,779 +$118,145 +122% 01 Oct 2021 31 Dec 2021 10-Q 17 Feb 2023 2023 Q2
Q3 2021 $635,928 $111,142 +$25,735 +30% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q1
Q2 2021 $610,193 $220,850 +$64,753 +41% 01 Apr 2021 30 Jun 2021 10-K 23 Sep 2022 2022 FY
Q1 2021 $545,440 $207,302 +$3,433 +1.7% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q3
Q4 2020 $542,007 $96,634 -$187,319 -66% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q2
Q3 2020 $729,326 $85,407 -$265,075 -76% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2022 Q1
Q2 2020 $994,401 $156,097 01 Apr 2020 30 Jun 2020 10-K 24 Sep 2021 2021 FY
Q1 2020 $203,869 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q3
Q4 2019 $283,953 01 Oct 2019 31 Dec 2019 10-Q 11 Feb 2021 2021 Q2
Q3 2019 $350,482 01 Jul 2019 30 Sep 2019 10-Q 17 Dec 2020 2021 Q1

InMed Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $28,964 -$108,750 -79% 01 Jul 2024 30 Jun 2025 10-Q 06 Nov 2025 2026 Q1
2024 $137,714 -$140,440 -50% 01 Jul 2023 30 Jun 2024 10-K 23 Sep 2025 2025 FY
2023 $278,154 -$419,740 -60% 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024 2024 FY
2022 $697,894 +$87,701 +14% 01 Jul 2021 30 Jun 2022 10-K 29 Sep 2023 2023 FY
2021 $610,193 -$384,208 -39% 01 Jul 2020 30 Jun 2021 10-K 23 Sep 2022 2022 FY
2020 $994,401 01 Jul 2019 30 Jun 2020 10-K 24 Sep 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.